Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 53.39% is in line with its 5-year average of 50.27%, near the high end of its 5-year range (44.59%–56.83%).
As of the fiscal period ended Tuesday, March 31, 2026. 3.13% above its 12-month average of 51.77%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
53.39%
DEBT TO ASSETS RATIO AVG TTM
51.77%
DEBT TO ASSETS RATIO AVG 3Y
49.12%
DEBT TO ASSETS RATIO AVG 5Y
50.57%
DEBT TO ASSETS RATIO AVG 10Y
54.30%
DEBT TO ASSETS RATIO AVG 15Y
54.37%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+3.13%
CURRENT VS 3Y AVG
+8.70%
CURRENT VS 5Y AVG
+5.58%
CURRENT VS 10Y AVG
-1.67%
CURRENT VS 15Y AVG
-1.81%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+18310.45%
vs the sector median at left
AbbVie Inc.
Market Cap
$458.11B
Debt to Assets Ratio
53.39%
TTM Avg
51.77%
3Y Avg
49.12%
5Y Avg
50.57%
Market Cap
$382.09B
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$211.18B
Debt to Assets Ratio
0.37%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$179.58B
Debt to Assets Ratio
0.17%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | $458.11B | 53.39% | 51.77% | 49.12% | 50.57% |
| UnitedHealth Group Incorporated (UNH)vs › | $382.09B | 0.25% | N/A | N/A | N/A |
| Merck & Co., Inc. (MRK)vs › | $323.72B | 0.37% | N/A | N/A | N/A |
| Johnson & Johnson (JNJ)vs › | $634.06B | 0.24% | N/A | N/A | N/A |
| AstraZeneca PLC (AZN)vs › | $262.31B | 0.26% | N/A | N/A | N/A |
| Novo Nordisk A/S (NVO)vs › | $216.72B | 0.24% | N/A | N/A | N/A |
| Thermo Fisher Scientific Inc. (TMO)vs › | $211.18B | 0.37% | N/A | N/A | N/A |
| Amgen Inc. (AMGN)vs › | $202.95B | 0.60% | N/A | N/A | N/A |
| Abbott Laboratories (ABT)vs › | $179.58B | 0.17% | N/A | N/A | N/A |
| Gilead Sciences, Inc. (GILD)vs › | $160.55B | 0.42% | N/A | N/A | N/A |
Debt/Assets
53.4%
Debt/Equity
-21.12
Current Ratio
0.67
Interest Coverage
6.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-03-31 | 53.39% |
| 2025-12-31 | 51.41% |
| 2025-09-30 | 51.34% |
| 2025-06-30 | 51.38% |
| 2025-03-31 | 51.33% |
| 2024-12-31 | 50.19% |
| 2024-09-30 | 49.56% |
| 2024-06-30 | 49.76% |
| 2024-03-31 | 49.71% |
| 2023-12-31 | 44.63% |
| 2023-09-30 | 44.59% |
| 2023-06-30 | 45.07% |
| 2023-03-31 | 46.15% |
| 2022-12-31 | 46.25% |
| 2022-09-30 | 49.25% |
| 2022-06-30 | 50.94% |
| 2022-03-31 | 51.30% |
| 2021-12-31 | 52.94% |
| 2021-09-30 | 54.23% |
| 2021-06-30 | 55.51% |
| 2021-03-31 | 56.83% |
| 2020-12-31 | 57.82% |
| 2020-09-30 | 58.19% |
| 2020-06-30 | 58.47% |
| 2020-03-31 | 73.52% |
| 2019-12-31 | 75.28% |
| 2019-09-30 | 65.24% |
| 2019-06-30 | 65.91% |
| 2019-03-31 | 66.16% |
| 2018-12-31 | 67.92% |
| 2018-09-30 | 61.22% |
| 2018-06-30 | 60.20% |
| 2018-03-31 | 53.77% |
| 2017-12-31 | 52.79% |
| 2017-09-30 | 54.90% |
| 2017-06-30 | 55.58% |
| 2017-03-31 | 56.27% |
| 2016-12-31 | 55.74% |
| 2016-09-30 | 56.00% |
| 2016-06-30 | 56.31% |
| 2016-03-31 | 59.41% |
| 2015-12-31 | 59.70% |
| 2015-09-30 | 58.59% |
| 2015-06-30 | 57.79% |
| 2015-03-31 | 57.20% |
| 2014-12-31 | 54.44% |
| 2014-09-30 | 51.99% |
| 2014-06-30 | 50.75% |
| 2014-03-31 | 50.27% |
| 2013-12-31 | 50.42% |
| 2013-09-30 | 52.42% |
| 2013-06-30 | 52.88% |
| 2013-03-31 | 55.35% |
| 2012-12-31 | 58.03% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.25% |
